Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis

Discussion These findings support the notion that the volume of distribution of sGFAP approximated by BV and BMI is a relevant variable and should therefore be controlled for when measuring sGFAP in MS, while this might not be necessary when measuring cGFAP concentrations.

http://nn.neurology.org/cgi/content/short/10/1/e200045?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - October 31, 2022 Category: Neurology Authors: Yalachkov, Y., Schäfer, J. H., Jakob, J., Friedauer, L., Steffen, F., Bittner, S., Foerch, C., Schaller-Paule, M. A. Tags: Research Article Source Type: research